Related Experiment Videos
What Is the Target Body Mass Index for Elective Hartmann's Reversal? A NSQIP Analysis Using Stratum-Specific
George L Wu1, Philip M Parel2, Matthew Zeller3
1Surgery Group of Los Angeles, Los Angeles, CA, USA.
Summary
This study identified body mass index (BMI) thresholds to predict complications after Hartmann's reversal surgery. Achieving lower BMI targets can help reduce postoperative morbidity for patients undergoing this procedure.
Area of Science:
- Colorectal Surgery
- Surgical Outcomes Research
- Obesity Medicine
Background:
- Obesity is linked to poor outcomes following Hartmann's reversal.
- Evidence-based body mass index (BMI) targets for elective Hartmann's reversal are lacking.
- This study aimed to identify BMI thresholds associated with 30-day postoperative morbidity.
Purpose of the Study:
- To establish data-driven body mass index (BMI) thresholds for elective Hartmann's reversal.
- To stratify patients based on BMI and associated risks of postoperative complications.
- To inform preoperative optimization strategies for patients undergoing Hartmann's reversal.
Main Methods:
- Retrospective cohort study using the ACS-NSQIP database (2015-2023).
- Included adults undergoing elective Hartmann's reversal (CPT codes 44626, 44227).
- Utilized stratum-specific likelihood ratio analysis and multivariable regression to identify BMI strata and associated complication risks.
Main Results:
- 16,027 patients were analyzed, identifying three risk-distinct BMI strata: 18.5-33.9 kg/m², 34-49.9 kg/m², and ≥50 kg/m².
- BMI 34-49.9 kg/m² (OR 1.38) and ≥50 kg/m² (OR 2.54) significantly increased odds of any postoperative complication.
- Elevated BMI correlated with increased odds of serious complications and surgical site infections, with rare mortality.
Conclusions:
- Data-driven BMI thresholds effectively stratify postoperative morbidity risk after Hartmann's reversal.
- Identified BMI thresholds can guide surgeons and patients in preoperative weight-loss optimization.
- These findings support evidence-based targets for improving surgical outcomes in obese patients.